Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2158829rdf:typepubmed:Citationlld:pubmed
pubmed-article:2158829lifeskim:mentionsumls-concept:C0010823lld:lifeskim
pubmed-article:2158829lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2158829lifeskim:mentionsumls-concept:C0005961lld:lifeskim
pubmed-article:2158829pubmed:issue3lld:pubmed
pubmed-article:2158829pubmed:dateCreated1990-6-1lld:pubmed
pubmed-article:2158829pubmed:abstractTextWe report the incidence of cytomegalovirus (CMV) seroconversion, infections and mortality in 169 consecutive thalassemic patients transplanted in Pesaro. We observed a 44% incidence of early seroconversion and a 52% incidence of late seroconversion. No relationship was found between seroconversion and acute or chronic graft-versus-host disease (GVHD) or rejection. The donor status did not influence the incidence of seroconversion, GVHD and rejection. Only three patients died of CMV infection (1.7%); in each case CMV disease was the final cause of death in patients with severe acute GVHD.lld:pubmed
pubmed-article:2158829pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2158829pubmed:languageenglld:pubmed
pubmed-article:2158829pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2158829pubmed:citationSubsetIMlld:pubmed
pubmed-article:2158829pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2158829pubmed:statusMEDLINElld:pubmed
pubmed-article:2158829pubmed:monthMarlld:pubmed
pubmed-article:2158829pubmed:issn0268-3369lld:pubmed
pubmed-article:2158829pubmed:authorpubmed-author:LucarelliGGlld:pubmed
pubmed-article:2158829pubmed:authorpubmed-author:PolchiPPlld:pubmed
pubmed-article:2158829pubmed:authorpubmed-author:BaroncianiDDlld:pubmed
pubmed-article:2158829pubmed:authorpubmed-author:GalimbertiMMlld:pubmed
pubmed-article:2158829pubmed:authorpubmed-author:AngelucciEElld:pubmed
pubmed-article:2158829pubmed:authorpubmed-author:DurazziS MSMlld:pubmed
pubmed-article:2158829pubmed:issnTypePrintlld:pubmed
pubmed-article:2158829pubmed:volume5lld:pubmed
pubmed-article:2158829pubmed:ownerNLMlld:pubmed
pubmed-article:2158829pubmed:authorsCompleteYlld:pubmed
pubmed-article:2158829pubmed:pagination167-72lld:pubmed
pubmed-article:2158829pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:meshHeadingpubmed-meshheading:2158829-...lld:pubmed
pubmed-article:2158829pubmed:year1990lld:pubmed
pubmed-article:2158829pubmed:articleTitleCytomegalovirus infections in thalassemic patients after bone marrow transplantation.lld:pubmed
pubmed-article:2158829pubmed:affiliationDivisione ematologica e Centro trapianto di midollo osseo di Muraglia, Ospedale di Pesaro, Italy.lld:pubmed
pubmed-article:2158829pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2158829pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed